Empasiprubart vs Immunoglobulin in Chronic Inflammatory Demyelinating Polyradiculoneuropathy: EMVIGORATE Phase Three Study Design (P1-9.022)

Rinaldi S., Brannagan T., Doneddu PE., Gable K., Stettner M., Van de Steen O., Budding K., Van de Walle I., Ellor S., Markov M., Allen J.

DOI

10.1212/wnl.0000000000213141

Type

Conference paper

Publisher

Ovid Technologies (Wolters Kluwer Health)

Publication Date

2026-06-09T00:00:00+00:00

Volume

106

Permalink More information Close